The basic premise of this pilot study is to enroll 40 patients over 3 years who have Stage II, III, or IV non-small cell lung cancer and are planned for definitive treatment with concurrent chemoradiation where a contrast enhanced 4DCT is planned.
Study Type
OBSERVATIONAL
Enrollment
40
Functional Lung Imaging with DECT and 4DCT
Abamson Cancer Center of the University of Pennsylvania
Philadelphia, Pennsylvania, United States
evaluate the reproducibility of PBV DECT imaging and 4DCT derived lung ventilation for evaluating lung function
Time frame: 3 years
correlate changes of PBV DECT and 4DCT lung function images seen at ~6 months with radiation dose and with patient reported outcome quality of life
Time frame: 3 years
• To propose a novel biologic (i.e. functional) dose volume algorithm to reduce PBV and 4DCT lung function changes
Time frame: 3 years
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.